Robert Kopec
Psychiatric/Mental Health · Tacoma, WANPI 1053746867
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 34.6% of the total. 2025 is the largest year on record at $1,558, 9.0 times the $173 reported in 2021. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$569
- Vanda Pharmaceuticals Inc.$236
- Axsome Therapeutics, Inc.$231
- Alkermes, Inc.$212
- Lundbeck LLC$180
- plus $831 from 12 others
What the payments were for
- Food & beverage$3,39398%
- Education$622%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,456 in reported general payments places this provider in the 90th percentile of 931 psychiatric/mental health providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 17 | $1,883 |
| Olanzapine | 22 | $1,029 |
| Aripiprazole | 39 | $839 |
| Gabapentin | 43 | $701 |
| Quetiapine Fumarate | 39 | $678 |
| Divalproex Sodium ErDivalproex Sodium | 29 | $637 |
| Bupropion XlBupropion Hcl | 29 | $433 |
| Lamotrigine | 60 | $372 |
| Clonazepam | 40 | $333 |
| Trazodone Hcl | 38 | $232 |
| Risperidone | 18 | $231 |
| Guanfacine Hcl ErGuanfacine Hcl | 14 | $208 |
| Lithium Carbonate | 20 | $199 |
| Escitalopram Oxalate | 21 | $177 |
| Methylphenidate Hcl | 12 | $160 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Tacoma
- Kerry CarrollTacoma$9K
- Ayub MwauraTacoma$7K
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
- Jennifer WilsonYakima$23K
- Kojo SarfoEllensburg$20K
- Brendan RoeVancouver$18K
- Jenna VoKent$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.